Globus Medical
GMED
263 hedge funds and large institutions have $2.6B invested in Globus Medical in 2017 Q4 according to their latest regulatory filings, with 48 funds opening new positions, 81 increasing their positions, 98 reducing their positions, and 36 closing their positions.
234% more call options, than puts
Call options by funds: $8.73M | Put options by funds: $2.62M
67% more funds holding in top 10
Funds holding in top 10: 3 → 5 (+2)
33% more first-time investments, than exits
New positions opened: 48 | Existing positions closed: 36
27% more capital invested
Capital invested by funds: $2.04B → $2.6B (+$557M)
4% more funds holding
Funds holding: 253 → 263 (+10)
7.9% less ownership
Funds ownership: 95.28% → 87.37% (-7.9%)
17% less repeat investments, than reductions
Existing positions increased: 81 | Existing positions reduced: 98
Top Buyers
Top Sellers
GMED Hedge Fund Activity: Q4 2017 in Review
263 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Globus Medical (GMED) for Q4 2017, worth a combined $2.6B — up 27% from $2.04B a quarter earlier.
Buyers outnumbered sellers: 48 funds opened new GMED positions and 36 closed out — a net gain of 12 holders — while 81 added to existing stakes and 98 trimmed.
The largest buyer was Fort Washington Investment Advisors, opening a new position worth an estimated $15.5M. The largest seller was Deutsche Bank, cutting an estimated $34.9M.
- 263 institutional investors held Globus Medical (GMED) as of Q4 2017, up from 253 in Q3 2017.
- Funds reported $2.6B of Globus Medical stock for Q4 2017, up 27% quarter-over-quarter.
- 48 funds opened new Globus Medical positions in Q4 2017 and 36 closed out, a net change of +12 holders.
- The largest Globus Medical buyer in Q4 2017 was Fort Washington Investment Advisors, an estimated $15.5M added.
- The largest Globus Medical seller in Q4 2017 was Deutsche Bank, an estimated $34.9M sold.
Based on aggregated 13F filings for Q4 2017.